Bisker-Leib Vered 4

4 · Ayala Pharmaceuticals, Inc. · Filed Jan 23, 2023

Form 4

Period: 2023-01-19

Director

Transactions

Award
Stock Option
2023-01-19+1,171→ 1,171 total
Exercise: $55.23Exp: 2031-06-09→ Common Stock (1,171 underlying)
Award
Stock Option
2023-01-19+1,171→ 1,171 total
Exercise: $8.69Exp: 2032-06-12→ Common Stock (1,171 underlying)
Award
Stock Option
2023-01-19+1,639→ 1,639 total
Exercise: $58.59Exp: 2030-08-17→ Common Stock (1,639 underlying)

Footnotes (6)

[F1]The option vests and becomes exercisable in thirty-six substantially equal monthly installments, such that the option shall be fully vested on August 18, 2023.
[F2]Received in the merger of Ayala Pharmaceuticals, Inc. ("Old Ayala") into the Issuer (the "Merger") in exchange for an employee stock option to acquire 8,750 shares of the common stock of Old Ayala for $10.98 per share.
[F3]This option is fully vested and exercisable.
[F4]Received in the Merger in exchange for an employee stock option to acquire 6,250 shares of the common stock of Old Ayala for $10.35 per share.
[F5]This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.
[F6]Received in the Merger in exchange for an employee stock option to acquire 6,250 shares of the common stock of Old Ayala for $1.63 per share.

Documents

1 file